{"pmid":32405839,"title":"[Prioritization of geriatric patients in care homes and residential homes in the context of the COVID pandemic].","text":["[Prioritization of geriatric patients in care homes and residential homes in the context of the COVID pandemic].","MMW Fortschr Med","Michels, Guido","Heppner, Hans-Jurgen","32405839"],"journal":"MMW Fortschr Med","authors":["Michels, Guido","Heppner, Hans-Jurgen"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405839","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1007/s15006-020-0477-9","keywords":["covid-19","coronasars-cov-2","elderly","frailty"],"topics":["Prevention"],"weight":1,"_version_":1666802845615128576,"score":9.490897,"similar":[{"pmid":32428997,"title":"Geriatric practice during and after the COVID-19 pandemic.","text":["Geriatric practice during and after the COVID-19 pandemic.","Geriatr Gerontol Int","Omura, Takuya","Araki, Atsushi","Shigemoto, Kazuhiro","Toba, Kenji","32428997"],"journal":"Geriatr Gerontol Int","authors":["Omura, Takuya","Araki, Atsushi","Shigemoto, Kazuhiro","Toba, Kenji"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32428997","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/ggi.13958","keywords":["covid-19","elderly","frailty","geriatric practice","sarcopenia"],"topics":["Prevention"],"weight":1,"_version_":1667252837659181057,"score":113.13481},{"pmid":32386946,"title":"Covid-19 cases in a no-Covid-19 geriatric acute care setting. A sporadic occurrence?","text":["Covid-19 cases in a no-Covid-19 geriatric acute care setting. A sporadic occurrence?","Eur J Intern Med","Fumagalli, Stefano","Salani, Bernardo","Gabbani, Luciano","Mossello, Enrico","Ungar, Andrea","32386946"],"journal":"Eur J Intern Med","authors":["Fumagalli, Stefano","Salani, Bernardo","Gabbani, Luciano","Mossello, Enrico","Ungar, Andrea"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32386946","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.ejim.2020.04.058","keywords":["atrial fibrillation","coronavirus","covid-19","elderly","frailty"],"topics":["Prevention"],"weight":1,"_version_":1666428892577005568,"score":109.16949},{"pmid":32369634,"title":"Guidelines for the management of diabetes in care homes during the Covid-19 pandemic.","text":["Guidelines for the management of diabetes in care homes during the Covid-19 pandemic.","The National Diabetes Stakeholders Covid-19 Response Group was formed in early April 2020 as a rapid action by the Joint British Diabetes Societies for Inpatient Care, Diabetes UK, the Association of British Clinical Diabetologists, and Diabetes Frail to address and support the special needs of residents with diabetes in UK care homes during Covid-19. It was becoming obvious that the care home sector was becoming a second wave of Covid-19 infection and that those with diabetes residing in care homes were at increased risk not only of susceptibility to infection but also to poorer outcomes. Its key purposes included minimising the morbidity and mortality associated with Covid-19 and assisting care staff to identify those residents with diabetes at highest risk of Covid-19 infection. The guidance was particularly created for care home managers, other care home staff, and specialist and non-specialist community nursing teams. The guidance covers the management of hyperglycaemia by discussion of various clinical scenarios that could arise, the management of hypoglycaemia, foot care and end of life care. In addition, it outlines the conditions where hospital admission is required. The guidance should be regarded as interim and will be updated as further medical and scientific evidence becomes available.","Diabet Med","Sinclair, Alan","Dhatariya, Ketan","Burr, Olivia","Nagi, Dinesh","Higgins, Kath","Hopkins, David","Patel, Mayank","Kar, Partha","Gooday, Catherine","Howarth, Dan","Abdelhafiz, Ahmed","Newland-Jones, Philip","O'Neill, Simon","32369634"],"abstract":["The National Diabetes Stakeholders Covid-19 Response Group was formed in early April 2020 as a rapid action by the Joint British Diabetes Societies for Inpatient Care, Diabetes UK, the Association of British Clinical Diabetologists, and Diabetes Frail to address and support the special needs of residents with diabetes in UK care homes during Covid-19. It was becoming obvious that the care home sector was becoming a second wave of Covid-19 infection and that those with diabetes residing in care homes were at increased risk not only of susceptibility to infection but also to poorer outcomes. Its key purposes included minimising the morbidity and mortality associated with Covid-19 and assisting care staff to identify those residents with diabetes at highest risk of Covid-19 infection. The guidance was particularly created for care home managers, other care home staff, and specialist and non-specialist community nursing teams. The guidance covers the management of hyperglycaemia by discussion of various clinical scenarios that could arise, the management of hypoglycaemia, foot care and end of life care. In addition, it outlines the conditions where hospital admission is required. The guidance should be regarded as interim and will be updated as further medical and scientific evidence becomes available."],"journal":"Diabet Med","authors":["Sinclair, Alan","Dhatariya, Ketan","Burr, Olivia","Nagi, Dinesh","Higgins, Kath","Hopkins, David","Patel, Mayank","Kar, Partha","Gooday, Catherine","Howarth, Dan","Abdelhafiz, Ahmed","Newland-Jones, Philip","O'Neill, Simon"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32369634","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/dme.14317","keywords":["covid-19","diabetes","care homes","frailty","insulin","residents"],"locations":["GBR","GBR"],"countries":["United Kingdom"],"countries_codes":["GBR|United Kingdom"],"topics":["Prevention"],"weight":1,"_version_":1666138496241238016,"score":87.59669},{"pmid":32208497,"title":"COVID-19 pandemic: palliative care for elderly and frail patients at home and in residential and nursing homes.","text":["COVID-19 pandemic: palliative care for elderly and frail patients at home and in residential and nursing homes.","Swiss Med Wkly","Kunz, Roland","Minder, Markus","32208497"],"journal":"Swiss Med Wkly","authors":["Kunz, Roland","Minder, Markus"],"date":"2020-03-26T11:00:00Z","year":2020,"_id":"32208497","source":"PubMed","week":"202013|Mar 23 - Mar 29","doi":"10.4414/smw.2020.20235","topics":["Treatment"],"weight":1,"_version_":1666138490199343104,"score":84.16868},{"pmid":32458356,"title":"The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.","text":["The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.","The early stages of the COVID-19 pandemic have focused on containing SARS-CoV-2 infection and identifying treatment strategies. While controlling this communicable disease is of utmost importance, the long-term effect on individuals with non-communicable diseases (NCD) is significant. Although certain NCDs appear to increase the severity of COVID-19 and mortality risk, SARS-CoV-2 infection in survivors with NCDs may also affect the progression of their pre-existing clinical conditions. Infection containment measures will have substantial short- and long-term consequences; social distancing and quarantine restrictions will reduce physical activity and increase other unhealthy lifestyles, thus increasing NCD risk factors and worsening clinical symptoms. Vitamin D levels might decrease and there might be a rise in mental health disorders. Many countries have made changes to routine management of NCD patients, e.g., cancelling non-urgent outpatient visits, which will have important implications for NCD management, diagnosis of new-onset NCDs, medication adherence, and NCD progression. We may have opportunities to learn from this unprecedented crisis on how to leverage healthcare technologies and improve procedures to optimize healthcare service provision. This article discusses how the COVID-19 outbreak and related infection control measures could hit the most frail individuals, worsening the condition of NCD patients, while further jeopardizing the sustainability of the healthcare systems. We suggest ways to define an integrated strategy that could involve both public institutional entities and the private sector to safeguard frail individuals and mitigate the impact of the outbreak.","Aging Clin Exp Res","Palmer, Katie","Monaco, Alessandro","Kivipelto, Miia","Onder, Graziano","Maggi, Stefania","Michel, Jean-Pierre","Prieto, Rita","Sykara, Georgia","Donde, Shaantanu","32458356"],"abstract":["The early stages of the COVID-19 pandemic have focused on containing SARS-CoV-2 infection and identifying treatment strategies. While controlling this communicable disease is of utmost importance, the long-term effect on individuals with non-communicable diseases (NCD) is significant. Although certain NCDs appear to increase the severity of COVID-19 and mortality risk, SARS-CoV-2 infection in survivors with NCDs may also affect the progression of their pre-existing clinical conditions. Infection containment measures will have substantial short- and long-term consequences; social distancing and quarantine restrictions will reduce physical activity and increase other unhealthy lifestyles, thus increasing NCD risk factors and worsening clinical symptoms. Vitamin D levels might decrease and there might be a rise in mental health disorders. Many countries have made changes to routine management of NCD patients, e.g., cancelling non-urgent outpatient visits, which will have important implications for NCD management, diagnosis of new-onset NCDs, medication adherence, and NCD progression. We may have opportunities to learn from this unprecedented crisis on how to leverage healthcare technologies and improve procedures to optimize healthcare service provision. This article discusses how the COVID-19 outbreak and related infection control measures could hit the most frail individuals, worsening the condition of NCD patients, while further jeopardizing the sustainability of the healthcare systems. We suggest ways to define an integrated strategy that could involve both public institutional entities and the private sector to safeguard frail individuals and mitigate the impact of the outbreak."],"journal":"Aging Clin Exp Res","authors":["Palmer, Katie","Monaco, Alessandro","Kivipelto, Miia","Onder, Graziano","Maggi, Stefania","Michel, Jean-Pierre","Prieto, Rita","Sykara, Georgia","Donde, Shaantanu"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32458356","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1007/s40520-020-01601-4","keywords":["covid-19","chronic diseases","coronavirus","elderly","frailty","ncd","sars-cov-2"],"e_drugs":["Vitamin D"],"topics":["Prevention"],"weight":1,"_version_":1667967698895634432,"score":82.29057}]}